SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-312751
Filing Date
2017-10-18
Accepted
2017-10-18 17:12:55
Documents
3
Period of Report
2017-10-13
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d470504d8k.htm 8-K 48875
2 EX-3.1 d470504dex31.htm EX-3.1 21223
3 EX-3.2 d470504dex32.htm EX-3.2 109634
  Complete submission text file 0001193125-17-312751.txt   181184
Mailing Address 19 FIRSTFIELD ROAD GAITHERSBURG MD 20878
Business Address 19 FIRSTFIELD ROAD GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Filer) CIK: 0001326190 (see all company filings)

IRS No.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32587 | Film No.: 171143139
SIC: 2834 Pharmaceutical Preparations